Miller Anestesia

379. Surawicz B: Relationship between electrocardio-

gram and electrolytes. Am Heart J 73:814, 1967.

380. Rimmer JM, Horn JF, Gennari FJ: Hyperkalemia as

a complication of drug therapy. Arch Intern Med

147:867, 1987.

381. Busch EH, Ventura HO, Lavie CJ: Heparin-induced

hyperkalemia. South Med J 80:1450, 1987.

382. Don BR, Sebastian A, Cheitlin M, et al: Pseudohy-

perkalemia caused by fist clenching during phlebo-

tomy. N Engl J Med 322:1290, 1990.

383. Kharasch ED, Bowdle TA: Hypokalemia before

induction of anesthesia and prevention by

adre-

noceptor antagonism. Anesth Analg 72:216, 1991.

384. Allon M,Dunlay R,Copkney C: Nebulised albuterol

for acute hyperkalemia in patients on hemodialysis.

Ann Intern Med 110:426, 1989.

385. Wong KC, Kawamura R, Hodges MR, et al: Acute

intravenous administration of potassium chloride

to furosemide pretreated dogs. Can J Anaesth

24:203, 1977.

386. Hahm TS, Cho HS, Lee KH, et al: Clonidine preme-

dication prevents preoperative hypokalemia. J Clin

Anesth 14:6–9, 2002.

387. Lawson DH: Adverse reactions to potassium chlo-

ride. Q J Med 43:433, 1974.

388. Vitez TS, Soper LE, Wong KC, Soper P: Chronic

hypokalemia and intraoperative dysrhythmias.

Anesthesiology 63:130, 1985.

389. Hirsch IA, Tomlinson DL, Slogoff S, Keats AS: The

overstated risk of preoperative hypokalemia.Anesth

Analg 67:131, 1988.

390. Olson RP, Schow AJ, McCann R, et al: Absence of

adverse outcomes in hyperkalemic patients under-

going vascular access surgery. Can J Anaesth

50:553–557, 2003.

391. Schow AJ, Lubarsky DA, Olson RP, Gan TJ: Can

succinylcholine be used safely in hyperkalemic

patients? Anesth Analg 95:19–122, 2002.

392. Wahr JA, Parks R, Boisvert D, et al: Preoperative

serum potassium levels and perioperative outcomes

in cardiac surgery patients. Multicenter Study of

Perioperative Ischemia Research Group. JAMA

281:2203–2210, 1999.

393. Cohen JD, Neaton JD, Prineas RJ, Daniels KA:

Diuretics, serum potassium and ventricular arr-

hythmias in the multiple risk factor intervention.

Am J Cardiol 60:548, 1987.

394. Holland OB, Nixon JV, Kuhnert L: Diuretic-induced

ventricular ectopic activity. Am J Med 70:762, 1981.

395. Tanifuji Y, Eger EIII: Brain sodium, potassium and

osmolality: Effect on anesthetic requirement.

Anesth Analg 57: 404, 1978.

396. Kornbluth A, Sachar DB: Ulcerative colitis practice

guidelines in adults.American College of Gastroen-

terology, Practice Parameters Committee. Am J

Gastroenterol 92:204, 1997.

397. Kahrilas PJ: Gastroesophageal reflux disease. JAMA

276:983, 1996.

398. Kurz A, Sessler DI, Lenhardt R: Perioperative nor-

mothermia to reduce the incidence of surgical-

wound infection and shorten hospitalization. Study

of Wound Infection and Temperature Group. N

Engl J Med 334:1209–1215, 1996.

399. Antimicrobial prophylaxis. Med Lett Drugs Ther

43, 92–97, 2001.

400. Jain NK, Larson DE, Schroeder KW, et al: Antibiotic

prophylaxis for percutaneous endoscopic gastros-

tomy. Ann Intern Med 107:824, 1987.

401. Gorbach SL: Antimicrobial prophylaxis for appen-

dectomy and colorectal surgery. Rev Infect Dis

13(Suppl 10): S815, 1991.

402. Peterson WJ: Peptic ulcer—an infectious disease?

West J Med 152:167, 1990.

403. Botero M, Fuchs R, Paulus DA, Lind DS: Carcinoid

heart disease: A case report and literature review.

J Clin Anesth 14:57–63, 2002.

404. Veall GRQ, Peacock JE, Bax NDS, Reilly CS: Review

of the anaesthetic management of 21 patients

undergoing laparotomy for carcinoid syndrome. Br

J Anaesth 72:335, 1994.

405. Longnecker M, Roizen MF: Patients with carcinoid

syndrome. Anesthesiol Clin North Am 5:313, 1987.

406. Weingarten TN, Abel MD, Connolly HM, et al:

Intraoperative management of patients with carci-

noid heart disease having valvular surgery:A review

of one hundred consecutive cases. Anesth Analg

105:1192–1199, 2007.

407. Marsh HM, Martin JK Jr, Kvols LK, et al: Carcinoid

crisis during anesthesia: Successful treatment with

a somatostatin analogue. Anesthesiology 66:89,

1987.

408. Watson JT, Badner NH, Ali MJ: The prophylactic

use of octreotide in a patient with ovarian carcinoid

and valvular heart disease. Can J Anaesth 37:798,

1990.

409. McCrirrick A, Hickman J: Octreotide for carcinoid

syndrome. Can J Anaesth 38:339, 1991.

410. Quinlivan JK, Roberts WA: Intraoperative octreo-

tide for refractory carcinoid-induced bronchos-

pasm. Anesth Analg 78:400, 1994.

411. Dilger JA, Rho EH, Que FG, Sprung J: Octreotide-

induced bradycardia and heart block during surgical

resection of a carcinoid tumor.AnesthAnalg 98:318–

320, 2004.

412. Zimmer C, Kienbaum P, Wiesemes R, Peters J:

Somatostatin does not prevent serotonin release

and flushing during chemoembolization of carci-

noid liver metastases.Anesthesiology 98:1007–1011,

2003.

413. Drossman DA, McKee DC, Sandler RS, et al:

Psychosocial factors in the irritable bowel syndrome.

A multivariate study of patients and non-patients

with irritable bowel syndrome. Gastroenterology

95:701, 1988.

414. Aitkenhead AR, Robinson S: Influence of morphine

and pethidine on the incidence of anastomotic

dehiscence after colonic surgery. Br J Anaesth

63:230P, 1989.

415. Green J, Beyar R, Sideman S, et al: The “jaundiced

heart”: A possible explanation for postoperative

shock in obstructive jaundice. Surgery 100:14,

1986.

416. Audet A-M, Goodnough LT: Practice strategies for

elective red blood cell transfusion. American

College of Physicians. Ann Intern Med 116:403,

1992.

417. Welch HG, Meehan KR, Goodnough LT: Prudent

strategies for elective red blood cell transfusion.

Ann Intern Med 116:393, 1992.

418. Crystal GJ, Rooney MW, Salem MR: Myocardial

blood flow and oxygen consumption during isovo-

lumic hemodilution alone and in combination with

adenosine-induced controlled hypotension. Anesth

Analg 67:539, 1988.

419. Nelson AH, Fleisher LA, Rosenbaum SH: Relation-

ship between postoperative anemia and cardiac

morbidity in high-risk vascular patients in the inten-

sive care unit. Crit Care Med 21:860–866, 1993.

420. Wu WC, Schifftner TL, Henderson WG, et al: Preo-

perative hematocrit levels and postoperative outco-

mes in older patients undergoing noncardiac

surgery. JAMA 297:2481–2488, 2007.

421. Bunn HF: Pathogenesis and treatment of a sickle

cell disease. N Engl J Med 337:762, 1997.

422. Adams RJ, McKie VC, Hsu L, et al: Prevention of a

first stroke by transfusions in children with sickle

cell anemia and abnormal results on transcranial

Doppler ultrasonography. N Engl J Med 339:5,

1998.

423. Platt OS, Thorington BD, Brambella DJ, et al: Pain

in sickle cell disease: Rates and risk factors. N Engl

J Med 325:11, 1991.

424. Vichinsky EP, Haberkern CM, Neumayr L, et al: A

comparison of conservative and aggressive trans-

fusion regimens in the perioperative management

of sickle cell disease. N Engl J Med 333:206,

1995.

425. Turhan A, Weiss LA, Mohandas N, et al: Primary

role for adherent leukocytes in sickle cell vascular

occlusion: A new paradigm. Proc Natl Acad Sci

U S A 99:3047–3051, 2002.

426. Dunn A, Davies A, Eckert G, et al: Intraoperative

death during caesarean section in a patient with

sickle-cell trait. Can J Anaesth 34:67, 1987.

427. Hemming AE: Pro: Exchange transfusion is requi-

red for sickle cell trait patients undergoing cardio-

pulmonary bypass. J Cardiothorac Vasc Anesth

18:663–665, 2004.

428. Messent M: Con: Exchange transfusion is not requi-

red for sickle cell trait patients undergoing cardio-

pulmonary bypass. J Cardiothorac Vasc Anesth

18:666–667, 2004.

429. Kark JA, Posey DM, Schumaeker HR, Ruehle CJ:

Sickle cell trait as a risk factor for sudden death in

physical training. N Engl J Med 317:781, 1987.

430. Bischoff RJ,Williamson A III,Dalali MJ,et al:Asses-

sment of the use of transfusion therapy periopera-

tivelyinpatientswithsicklecellhemoglobinopathies.

Ann Surg 207:434, 1988.

431. Tuck SM, James CE, Brewster EM, et al: Pro-

phylactic blood transfusion in maternal sickle cell

syndromes. Br J Obstet Gynaecol 94:121, 1987.

432. Beutler E: The common anemias. JAMA 259:2433,

1988.

433. Orr D: Difficult intubation:A hazard in thalassemia.

A case report. Br J Anaesth 39:585, 1967.

434. Pootrakul P, Hungsprenges S, Fucharoen S, et al:

Relation between erythropoiesis and bone metabo-

lism in thalassemia. N Engl J Med 304:1470–1473,

1981.

435. Muretto P, Angelucci E, Lucarelli G: Reversibility of

cirrhosis in patients cured of thalassemia by bone

marrow transplantation. Ann Intern Med 136:667–

672, 2002.

436. Lux SE,Wolfe LC: Inherited disorders of the red cell

membrane skeleton. Pediatr Clin North Am 27:463,

1980.

437. Beutler E: Glucose-6-phosphate dehydrogenase

deficiency. N Engl J Med 324:169, 1991.

438. Engelfriet CP, Overbeeke MA, van der Berne AE:

Autoimmune hemolytic anemia. Semin Hematol

29:3, 1992.

439. Schilling RF: Is nitrous oxide a dangerous anesthetic

for vitamin B

–deficient subjects? JAMA 255:1605,

1986.

440. Beebe DS, Bergen L, Palahniuk RJ: Anesthesia uti-

lizing plasmapheresis and forced air warming in a

patient with severe cold agglutinin hemolytic

anemia. Anesth Analg 76:1144, 1993.

441. Goodnough LT, Rudnick S, Price TH, et al: Increa-

sed preoperative collection of autologous blood

with recombinant human erythropoietin therapy.

N Engl J Med 321:1163, 1989.

442. Quesenberg PJ, Schafer AI, Schreiber AD, et al:

Hematology.

American College of Physicians:

Medical Knowledge Self-Assessment. Philadelphia,

American College of Physicians, 1991, pp 374.

443. Tobias JD, Furman WL: Anesthetic considerations

in patients receiving colony-stimulating factors

(G-CSF and GM-CSF). Anesthesiology 75:536,

1991.

444. Alavi JB, Root RK, Djerassi I, et al: A randomized

clinical trial of granulocyte transfusion for infection

in acute leukemia. N Engl J Med 296:706, 1977.

445. Gabrilove JL, Jakubowski A, Scher H, et al: Effect of

granulocyte colony stimulating factor on neutrope-

nia and associated morbidity due to chemotherapy

for transitional-cell carcinoma of the urothelium.

N Engl J Med 318:1414, 1988.

446. Quie PG: The white cells: Use of granulocyte trans-

fusions. Rev Infect Dis 9:189, 1987.

447. Crawford SW, Fisher L: Predictive value of pulmo-

nary function tests before marrow transplantation.

Chest 101:1257, 1992.

448. McCrae KR, Bussel JB, Mannucci PM, et al: Plate-

lets: An update on diagnosis and management of

thrombocytopenic disorders. Hematology (Am Soc

Hematol Educ Program) 282–305, 2001.

449. Kelton JG: Management of the pregnant patient

with idiopathic thrombocytopenic purpura. Ann

Intern Med 99:796, 1983.

450. Douzinas EE, Markakis K, Karabinis A, et al: Early

plasmapheresis in patients with thrombotic throm-

bocytopenic purpura. Crit Care Med 20:57, 1992.

451. Lewis BE,Wallis DE, Berkowitz MD, et al: Argatro-

ban anticoagulant therapy in patients with

Implicaciones anestésicas de las enfermedades concurrentes

913

Sección III

Control de la anestesia